Yasuda Hideo, Kato Akihiko, Fujigaki Yoshihide, Hishida Akira
First Department of Medicine, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
Ther Apher Dial. 2010 Dec;14(6):541-6. doi: 10.1111/j.1744-9987.2010.00826.x.
No population-based studies have described the prevalence of acute kidney injury (AKI) treated with renal replacement therapy (RRT) in Japan. This study prospectively examined the incidence of AKI requiring RRT by surveying 16 hospitals in Shizuoka prefecture from January to October 2006. The subjects comprised 242 patients treated with RRT during the observation period. The estimated incidence of AKI requiring RRT was 13.3 cases/100,000 persons/year in this area. Major contributing factors for AKI were sepsis (34%), cardiac shock (23%), and major surgery (12%). The in-hospital mortality rate was 47.1%, paralleling the increased number of insufficient organs. Oliguria was a risk factor for in-hospital mortality. These findings suggest that the incidence of AKI treated with RRT in Japan is comparable to those in Western countries, and the prognosis of AKI patients requiring RRT is also poor in Japanese patients.
在日本,尚无基于人群的研究描述接受肾脏替代治疗(RRT)的急性肾损伤(AKI)的患病率。本研究通过对静冈县的16家医院在2006年1月至10月期间进行调查,前瞻性地研究了需要RRT的AKI的发病率。研究对象包括在观察期内接受RRT治疗的242例患者。该地区需要RRT的AKI的估计发病率为13.3例/100,000人/年。AKI的主要促成因素为脓毒症(34%)、心源性休克(23%)和大手术(12%)。住院死亡率为47.1%,与器官功能不全数量的增加相一致。少尿是住院死亡的一个危险因素。这些发现表明,在日本接受RRT治疗的AKI的发病率与西方国家相当,并且需要RRT的AKI患者在日本患者中的预后也很差。